NCT01808599 2026-01-15Phase II Study of Chlorambucil and Subcutaneous Rituximab in Patients With Extranodal MALT LymphomaInternational Extranodal Lymphoma Study Group (IELSG)Phase 2 Active not recruiting112 enrolled